30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Repare Therapeutics Inc (RPTX)

Track

Stock chart
Ticker: RPTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Forte, Steve
Senior Officer of Issuer
1 purchase — total 2,160 USD
Planned buy 15 Aug 2025
Value US$1,052,979.91 | Price 491.71 | Shares 14,828
Planned buy 15 Aug 2025
Value US$1,874,115.19 | Price 485.74 | Shares 23,568
Sale 13 Mar 2025
Value US$6,396.54 | Price 1.14 | Shares 5,611
Sale 13 Mar 2025
Value US$24,144.06 | Price 1.14 | Shares 21,179
Sale 13 Mar 2025
Value US$4,099.44 | Price 1.14 | Shares 3,596
Sale 13 Mar 2025
Value US$4,330.86 | Price 1.14 | Shares 3,799
Sale 13 Mar 2025
Value US$2,037.18 | Price 1.14 | Shares 1,787
Sale 12 Mar 2025
Value US$24,144.06 | Price 1.14 | Shares 21,179
Sale 12 Mar 2025
Value US$7,847.76 | Price 1.14 | Shares 6,884
Sale 12 Mar 2025
Value US$4,099.44 | Price 1.14 | Shares 3,596
Sale 12 Mar 2025
Value US$6,396.54 | Price 1.14 | Shares 5,611
Planned buy 15 Feb 2025
Value US$2,160.00 | Price 1.08 | Shares 2,000
Planned buy 15 Feb 2025
Value US$2,160.00 | Price 1.08 | Shares 2,000
Planned buy 15 Feb 2025
Value US$2,160.00 | Price 1.08 | Shares 2,000
Planned buy 15 Aug 2024
Value US$2,282.25 | Price 2.55 | Shares 895
Planned buy 15 Aug 2024
Value US$2,282.25 | Price 2.55 | Shares 895
Planned buy 15 Aug 2024
Value US$3,233.40 | Price 2.55 | Shares 1,268
Planned sale 1 Apr 2024
Value US$11,533.33 | Price 4.63 | Shares 2,491
Planned sale 1 Apr 2024
Value US$1,910.60 | Price 4.66 | Shares 410
Planned sale 1 Apr 2024
Value US$3,637.29 | Price 4.61 | Shares 789
Planned sale 1 Apr 2024
Value US$1,398.00 | Price 4.66 | Shares 300
Planned sale 28 Mar 2024
Value US$12,243.00 | Price 4.62 | Shares 2,650
Planned sale 28 Mar 2024
Value US$2,088.00 | Price 4.64 | Shares 450
Planned sale 28 Mar 2024
Value US$3,811.50 | Price 4.62 | Shares 825
Planned sale 28 Mar 2024
Value US$2,320.00 | Price 4.64 | Shares 500
Planned sale 28 Mar 2024
Value US$2,088.00 | Price 4.64 | Shares 450
Planned sale 28 Mar 2024
Value US$1,415.20 | Price 4.64 | Shares 305
Planned sale 28 Mar 2024
Value US$4,185.00 | Price 4.65 | Shares 900
Planned sale 28 Mar 2024
Value US$12,243.00 | Price 4.62 | Shares 2,650
Planned sale 28 Mar 2024
Value US$2,320.00 | Price 4.64 | Shares 500
Planned sale 28 Mar 2024
Value US$2,325.00 | Price 4.65 | Shares 500
Planned sale 28 Mar 2024
Value US$3,811.50 | Price 4.62 | Shares 825
Planned sale 28 Mar 2024
Value US$2,134.44 | Price 4.62 | Shares 462
Planned sale 27 Mar 2024
Value US$2,079.00 | Price 4.62 | Shares 450
Planned sale 27 Mar 2024
Value US$1,403.00 | Price 4.60 | Shares 305
Planned sale 27 Mar 2024
Value US$4,149.00 | Price 4.61 | Shares 900
Planned sale 27 Mar 2024
Value US$12,269.50 | Price 4.63 | Shares 2,650
Planned sale 27 Mar 2024
Value US$2,310.00 | Price 4.62 | Shares 500
Planned sale 27 Mar 2024
Value US$2,310.00 | Price 4.62 | Shares 500
Planned sale 27 Mar 2024
Value US$3,811.50 | Price 4.62 | Shares 825
Planned sale 27 Mar 2024
Value US$2,171.40 | Price 4.62 | Shares 470
Planned sale 27 Mar 2024
Value US$12,269.50 | Price 4.63 | Shares 2,650
Planned sale 27 Mar 2024
Value US$2,079.00 | Price 4.62 | Shares 450
Planned sale 27 Mar 2024
Value US$2,310.00 | Price 4.62 | Shares 500
Planned sale 27 Mar 2024
Value US$3,811.50 | Price 4.62 | Shares 825
Planned sale 26 Mar 2024
Value US$2,074.50 | Price 4.61 | Shares 450
Planned sale 26 Mar 2024
Value US$1,403.00 | Price 4.60 | Shares 305
Planned sale 26 Mar 2024
Value US$4,149.00 | Price 4.61 | Shares 900
Planned sale 26 Mar 2024
Value US$12,296.00 | Price 4.64 | Shares 2,650
Planned sale 26 Mar 2024
Value US$2,300.00 | Price 4.60 | Shares 500
Planned sale 26 Mar 2024
Value US$2,305.00 | Price 4.61 | Shares 500
Planned sale 26 Mar 2024
Value US$3,795.00 | Price 4.60 | Shares 825
Planned sale 26 Mar 2024
Value US$2,171.40 | Price 4.62 | Shares 470
Planned sale 26 Mar 2024
Value US$12,296.00 | Price 4.64 | Shares 2,650
Proposed sale 26 Mar 2024
Value US$481,415.00 | Price 4.84 | Shares 99,466
Planned sale 26 Mar 2024
Value US$2,074.50 | Price 4.61 | Shares 450
Planned sale 26 Mar 2024
Value US$2,300.00 | Price 4.60 | Shares 500
Planned sale 26 Mar 2024
Value US$3,795.00 | Price 4.60 | Shares 825
Planned sale 25 Mar 2024
Value US$2,151.00 | Price 4.78 | Shares 450
Planned sale 25 Mar 2024
Value US$1,460.95 | Price 4.79 | Shares 305
Planned sale 25 Mar 2024
Value US$4,302.00 | Price 4.78 | Shares 900
Planned sale 25 Mar 2024
Value US$12,693.50 | Price 4.79 | Shares 2,650
Planned sale 25 Mar 2024
Value US$2,390.00 | Price 4.78 | Shares 500
Planned sale 25 Mar 2024
Value US$2,395.00 | Price 4.79 | Shares 500
Planned sale 25 Mar 2024
Value US$3,951.75 | Price 4.79 | Shares 825
Planned sale 25 Mar 2024
Value US$2,251.30 | Price 4.79 | Shares 470
Proposed sale 25 Mar 2024
Value US$20,000.00 | Price 4.89 | Shares 4,089
Planned sale 25 Mar 2024
Value US$3,951.75 | Price 4.79 | Shares 825
Planned sale 25 Mar 2024
Value US$12,693.50 | Price 4.79 | Shares 2,650
Proposed sale 25 Mar 2024
Value US$62,313.16 | Price 4.76 | Shares 13,091
Planned sale 25 Mar 2024
Value US$2,151.00 | Price 4.78 | Shares 450
Planned sale 25 Mar 2024
Value US$2,390.00 | Price 4.78 | Shares 500
Proposed sale 25 Mar 2024
Value US$10,806.90 | Price 4.89 | Shares 2,210
Proposed sale 25 Mar 2024
Value US$11,247.00 | Price 4.89 | Shares 2,300
Planned buy 15 Feb 2024
Value US$11,820.00 | Price 5.91 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-17 2025-08-15 PP Planned purchase
Forte, Steve

Senior Officer of Issuer

Officer
14,828 -18.5%
491.71
US$1,052,980 		14,828 -18.5% 491.71 US$1,052,980
2025-11-17 2025-08-15 PP Planned purchase
Alves, Sandra

Senior Officer of Issuer

Officer
23,568 +32.1%
485.74
US$1,874,115 		23,568 +32.1% 485.74 US$1,874,115
2025-03-14 2025-03-13 S Sale
1.5
Zinda, Michael

Senior Officer of Issuer

Officer
79,583 +49.3%
47.34
US$4,345,610 		79,583 +49.3% 47.34 US$4,345,610
2025-03-14 2025-03-13 S Sale
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
21,179 -32.2%
1.14
US$24,144 		21,179 -32.2% 1.14 US$24,144
2025-03-14 2025-03-13 S Sale
1.5
Koehler, Maria

Senior Officer of Issuer

Officer
3,596 -1.7%
1.14
US$4,099 		3,596 -1.7% 1.14 US$4,099
2025-03-14 2025-03-13 S Sale
1.5
Herman, Philip

Senior Officer of Issuer

Officer
3,799 -25.9%
1.14
US$4,331 		3,799 -25.9% 1.14 US$4,331
2025-03-14 2025-03-13 S Sale
1.5
Bélanger, Daniel

Senior Officer of Issuer

Officer
1,787 -21.2%
1.14
US$2,037 		1,787 -21.2% 1.14 US$2,037
2025-03-14 2025-03-12 S Sale
2.2
Segal Lloyd Mitchell

PRESIDENT AND CEO

Executive Director
21,179 -14.5%
1.14
US$24,144 		21,179 -14.5% 1.14 US$24,144
2025-03-14 2025-03-12 S Sale
1.5
Forte Steve

EVP, CHIEF FINANCIAL OFFICER

Officer
6,884 -11.2%
1.14
US$7,848 		6,884 -11.2% 1.14 US$7,848
2025-03-14 2025-03-12 S Sale
1.5
Koehler Maria

EVP, CHIEF MEDICAL OFFICER

Officer
3,596 -1.6%
1.14
US$4,099 		3,596 -1.6% 1.14 US$4,099
2025-03-14 2025-03-12 S Sale
2.7
Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER

Officer
5,611 -6.5%
1.14
US$6,397 		5,611 -6.5% 1.14 US$6,397
2025-03-07 2025-02-15 PP Planned purchase
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
2,000 +8.2%
1.08
US$2,160 		2,000 +8.2% 1.08 US$2,160
2025-03-07 2025-02-15 PP Planned purchase
Forte, Steve

Senior Officer of Issuer

Officer
2,000 +13.1%
1.08
US$2,160 		2,000 +13.1% 1.08 US$2,160
2025-03-07 2025-02-15 PP Planned purchase
Black, Cameron

Senior Officer of Issuer

Officer
2,000 +7.4%
1.08
US$2,160 		2,000 +7.4% 1.08 US$2,160
2025-03-07 2024-08-15 PP Planned purchase
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
895 +3.8%
2.55
US$2,282 		895 +3.8% 2.55 US$2,282
2025-03-07 2024-08-15 PP Planned purchase
Forte, Steve

Senior Officer of Issuer

Officer
895 +6.2%
2.55
US$2,282 		895 +6.2% 2.55 US$2,282
2025-03-07 2024-08-15 PP Planned purchase
Black, Cameron

Senior Officer of Issuer

Officer
1,268 +5.0%
2.55
US$3,233 		1,268 +5.0% 2.55 US$3,233
2024-04-01 2024-04-01 PlS Planned sale
2.2
Segal Lloyd Mitchell

PRESIDENT AND CEO

Executive Director
2,491 -2.3%
4.63
US$11,533 		2,491 -2.3% 4.63 US$11,533
2024-04-01 2024-04-01 PlS Planned sale
2.7
Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER

Officer
410 -0.6%
4.66
US$1,911 		410 -0.6% 4.66 US$1,911
2024-04-01 2024-04-01 PlS Planned sale
1.5
Forte Steve

EVP, CHIEF FINANCIAL OFFICER

Officer
789 -1.7%
4.61
US$3,637 		789 -1.7% 4.61 US$3,637
2024-04-01 2024-04-01 PlS Planned sale
1.5
Koehler Maria

EVP, CHIEF MEDICAL OFFICER

Officer
300 -0.1%
4.66
US$1,398 		300 -0.1% 4.66 US$1,398
2024-04-01 2024-03-28 PlS Planned sale
2.2
Segal Lloyd Mitchell

PRESIDENT AND CEO

Executive Director
2,650 -2.4%
4.62
US$12,243 		2,650 -2.4% 4.62 US$12,243
2024-04-01 2024-03-28 PlS Planned sale
2.7
Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.64
US$2,088 		450 -0.6% 4.64 US$2,088
2024-04-01 2024-03-28 PlS Planned sale
1.5
Forte Steve

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.8%
4.62
US$3,812 		825 -1.8% 4.62 US$3,812
2024-04-01 2024-03-28 PlS Planned sale
1.5
Koehler Maria

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.64
US$2,320 		500 -0.2% 4.64 US$2,320
2024-03-28 2024-03-28 PlS Planned sale
1.5
Zinda, Michael

Senior Officer of Issuer

Officer
450 -1.1%
4.64
US$2,088 		450 -1.1% 4.64 US$2,088
2024-03-28 2024-03-28 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
305 -1.1%
4.64
US$1,415 		305 -1.1% 4.64 US$1,415
2024-03-28 2024-03-28 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
900 -3.2%
4.65
US$4,185 		900 -3.2% 4.65 US$4,185
2024-03-28 2024-03-28 PlS Planned sale
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
2,650 -10.1%
4.62
US$12,243 		2,650 -10.1% 4.62 US$12,243
2024-03-28 2024-03-28 PlS Planned sale
1.5
Koehler, Maria

Senior Officer of Issuer

Officer
500 -0.2%
4.64
US$2,320 		500 -0.2% 4.64 US$2,320
2024-03-28 2024-03-28 PlS Planned sale
1.5
Herman, Philip

Senior Officer of Issuer

Officer
500 -10.8%
4.65
US$2,325 		500 -10.8% 4.65 US$2,325
2024-03-28 2024-03-28 PlS Planned sale
Forte, Steve

Senior Officer of Issuer

Officer
825 -6.0%
4.62
US$3,812 		825 -6.0% 4.62 US$3,812
2024-03-28 2024-03-28 PlS Planned sale
Black, Cameron

Senior Officer of Issuer

Officer
462 -1.9%
4.62
US$2,134 		462 -1.9% 4.62 US$2,134
2024-03-28 2024-03-27 PlS Planned sale
1.5
Zinda, Michael

Senior Officer of Issuer

Officer
450 -1.1%
4.62
US$2,079 		450 -1.1% 4.62 US$2,079
2024-03-28 2024-03-27 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
305 -1.1%
4.60
US$1,403 		305 -1.1% 4.60 US$1,403
2024-03-28 2024-03-27 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
900 -3.1%
4.61
US$4,149 		900 -3.1% 4.61 US$4,149
2024-03-28 2024-03-27 PlS Planned sale
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
2,650 -9.1%
4.63
US$12,270 		2,650 -9.1% 4.63 US$12,270
2024-03-28 2024-03-27 PlS Planned sale
1.5
Koehler, Maria

Senior Officer of Issuer

Officer
500 -0.2%
4.62
US$2,310 		500 -0.2% 4.62 US$2,310
2024-03-28 2024-03-27 PlS Planned sale
1.5
Herman, Philip

Senior Officer of Issuer

Officer
500 -9.8%
4.62
US$2,310 		500 -9.8% 4.62 US$2,310
2024-03-28 2024-03-27 PlS Planned sale
Forte, Steve

Senior Officer of Issuer

Officer
825 -5.6%
4.62
US$3,812 		825 -5.6% 4.62 US$3,812
2024-03-28 2024-03-27 PlS Planned sale
Black, Cameron

Senior Officer of Issuer

Officer
470 -1.9%
4.62
US$2,171 		470 -1.9% 4.62 US$2,171
2024-03-27 2024-03-27 PlS Planned sale
2.2
Segal Lloyd Mitchell

PRESIDENT AND CEO

Executive Director
2,650 -3.1%
4.63
US$12,270 		2,650 -3.1% 4.63 US$12,270
2024-03-27 2024-03-27 PlS Planned sale
2.7
Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.62
US$2,079 		450 -0.6% 4.62 US$2,079
2024-03-27 2024-03-27 PlS Planned sale
1.5
Koehler Maria

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.62
US$2,310 		500 -0.2% 4.62 US$2,310
2024-03-27 2024-03-27 PlS Planned sale
1.5
Forte Steve

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.9%
4.62
US$3,812 		825 -1.9% 4.62 US$3,812
2024-03-28 2024-03-26 PlS Planned sale
1.5
Zinda, Michael

Senior Officer of Issuer

Officer
450 -1.0%
4.61
US$2,074 		450 -1.0% 4.61 US$2,074
2024-03-28 2024-03-26 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
305 -1.0%
4.60
US$1,403 		305 -1.0% 4.60 US$1,403
2024-03-28 2024-03-26 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
900 -3.0%
4.61
US$4,149 		900 -3.0% 4.61 US$4,149
2024-03-28 2024-03-26 PlS Planned sale
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
2,650 -8.4%
4.64
US$12,296 		2,650 -8.4% 4.64 US$12,296
2024-03-28 2024-03-26 PlS Planned sale
1.5
Koehler, Maria

Senior Officer of Issuer

Officer
500 -0.2%
4.60
US$2,300 		500 -0.2% 4.60 US$2,300
2024-03-28 2024-03-26 PlS Planned sale
1.5
Herman, Philip

Senior Officer of Issuer

Officer
500 -8.9%
4.61
US$2,305 		500 -8.9% 4.61 US$2,305
2024-03-28 2024-03-26 PlS Planned sale
Forte, Steve

Senior Officer of Issuer

Officer
825 -5.3%
4.60
US$3,795 		825 -5.3% 4.60 US$3,795
2024-03-28 2024-03-26 PlS Planned sale
Black, Cameron

Senior Officer of Issuer

Officer
470 -1.9%
4.62
US$2,171 		470 -1.9% 4.62 US$2,171
2024-03-27 2024-03-26 PlS Planned sale
2.2
Segal Lloyd Mitchell

PRESIDENT AND CEO

Executive Director
2,650 -3.0%
4.64
US$12,296 		2,650 -3.0% 4.64 US$12,296
2024-03-27 2024-03-26 PlS Planned sale
2.7
Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.61
US$2,074 		450 -0.6% 4.61 US$2,074
2024-03-27 2024-03-26 PlS Planned sale
1.5
Koehler Maria

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.60
US$2,300 		500 -0.2% 4.60 US$2,300
2024-03-27 2024-03-26 PlS Planned sale
1.5
Forte Steve

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.9%
4.60
US$3,795 		825 -1.9% 4.60 US$3,795
2024-03-26 2024-03-26 PrS Proposed sale
2.2
Segal Lloyd Mitchell

Officer

Officer
99,466
4.84
US$481,415 		99,466 4.84 US$481,415
2024-03-28 2024-03-25 PlS Planned sale
1.5
Zinda, Michael

Senior Officer of Issuer

Officer
450 -1.0%
4.78
US$2,151 		450 -1.0% 4.78 US$2,151
2024-03-28 2024-03-25 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
305 -1.0%
4.79
US$1,461 		305 -1.0% 4.79 US$1,461
2024-03-28 2024-03-25 PlS Planned sale
Seth, Kim

Senior Officer of Issuer

Officer
900 -2.9%
4.78
US$4,302 		900 -2.9% 4.78 US$4,302
2024-03-28 2024-03-25 PlS Planned sale
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
2,650 -7.7%
4.79
US$12,694 		2,650 -7.7% 4.79 US$12,694
2024-03-28 2024-03-25 PlS Planned sale
1.5
Koehler, Maria

Senior Officer of Issuer

Officer
500 -0.2%
4.78
US$2,390 		500 -0.2% 4.78 US$2,390
2024-03-28 2024-03-25 PlS Planned sale
1.5
Herman, Philip

Senior Officer of Issuer

Officer
500 -8.2%
4.79
US$2,395 		500 -8.2% 4.79 US$2,395
2024-03-28 2024-03-25 PlS Planned sale
Forte, Steve

Senior Officer of Issuer

Officer
825 -5.1%
4.79
US$3,952 		825 -5.1% 4.79 US$3,952
2024-03-28 2024-03-25 PlS Planned sale
Black, Cameron

Senior Officer of Issuer

Officer
470 -1.9%
4.79
US$2,251 		470 -1.9% 4.79 US$2,251
2024-03-27 2024-03-25 PrS Proposed sale
1.5
Forte Steve

Officer

Officer
4,089
4.89
US$20,000 		4,089 4.89 US$20,000
2024-03-27 2024-03-25 PlS Planned sale
2.2
Segal Lloyd Mitchell

PRESIDENT AND CEO

Executive Director
2,650 -2.9%
4.79
US$12,694 		2,650 -2.9% 4.79 US$12,694
2024-03-27 2024-03-25 PlS Planned sale
2.7
Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.78
US$2,151 		450 -0.6% 4.78 US$2,151
2024-03-27 2024-03-25 PlS Planned sale
1.5
Koehler Maria

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.78
US$2,390 		500 -0.2% 4.78 US$2,390
2024-03-27 2024-03-25 PlS Planned sale
1.5
Forte Steve

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.8%
4.79
US$3,952 		825 -1.8% 4.79 US$3,952
2024-03-25 2024-03-25 PrS Proposed sale
2.7
MICHAEL ZINDA

Officer

Officer
2,210
4.89
US$10,807 		2,210 4.89 US$10,807
2024-03-25 2024-03-25 PrS Proposed sale
1.5
MARIA KOEHLER

Officer

Officer
2,300
4.89
US$11,247 		2,300 4.89 US$11,247
2024-03-25 2024-03-25 PrS Proposed sale
2.2
Segal Lloyd Mitchell

Officer; Director

Executive Director
13,091
4.76
US$62,313 		13,091 4.76 US$62,313
2024-03-04 2024-02-15 PP Planned purchase
2.2
SEGAL, Lloyd M.

Senior Officer of Issuer

Officer
2,000 +32.6%
5.91
US$11,820 		2,000 +32.6% 5.91 US$11,820
Explore more

More insider trading research around Repare Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America